title: Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients.
abstract: OBJECTIVE
  The role of selenium in preventing cardiovascular diseases has been largely described. Oxidative stress and the subsequent activation of nuclear factor-kappa B (NF-kappaB) have been linked to the development of vascular complications. We investigated the effects of selenium supplementation in type 2 diabetic patients on several oxidative stress parameters and NF-kappaB activity.
  
  
  METHODS
  We enrolled 56 type 2 diabetic patients with similar glycaemic control: 21 were supplemented by selenium (960 micro g d(-1), 3 months) and 27 received a placebo, and 10 nondiabetic subjects formed the control group. To determine NF-kappaB activation, we used an electrophoretic mobility shift assay followed by a semi-quantitative determination of NF-kappaB in peripheral blood mononuclear cells.
  
  
  RESULTS
  Selenium treatment resulted in a significant increase in plasma selenium and red-cell Se GSH px activity. It had no effect on lipid peroxidation measured by malone-dialdehyde (MDA) or on red-cell Cu/Zn SOD. NF-kappaB activity was increased by 80% in diabetic patients. In patients receiving selenium supplementation, selenium NF-kappaB activity was significantly reduced, reaching the same level as the nondiabetic control group.
  
  
  CONCLUSIONS
  In type 2 diabetic patients, activation of NF-kappaB measured in peripheral blood monocytes can be reduced by selenium supplementation, confirming its importance in the prevention of cardiovascular diseases.
authors.affiliation: Laboratoire d'Etude de la Physiopathologie de l'Hypoxie, La Tronche, France. patrice.faure@ujf-grenoble.fr
authors.forename: P
authors.initials: P
authors.lastname: Faure
authors.forename: O
authors.initials: O
authors.lastname: Ramon
authors.forename: A
authors.initials: A
authors.lastname: Favier
authors.forename: S
authors.initials: S
authors.lastname: Halimi
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D019587:Dietary Supplements; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D008875:Middle Aged; D016328:NF-kappa B / Q000378:metabolism*; D012643:Selenium / Q000008:administration & dosage* / Q000097:blood
chemical_list: D016328:NF-kappa B; D012643:Selenium